| General Information of This Metabolic Reaction (MR) (ID:
MR004240) |
| Formula |
|
| Reactant |
Esculin |
Product |
Esculetin |
|
Reactant Info
|
Product Info
|
|
Metabolic Enzyme
|
Acid beta-glucosidase (GBA1)
|
DME Info
|
|
Metabolic Type
|
Hydrolysis
-
Hydrolyzation
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| Other MR(s) Related to The Product of This MR |
|
Other MR(s) That Produce The Product of This MR
|
|
|
| References |
| 1 |
A prodrug approach to the use of coumarins as potential therapeutics for superficial mycoses. PLoS One. 2013 Nov 18;8(11):e80760.
|
| 2 |
Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.